Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtre
1.
Acta cir. bras ; 35(1): e202000104, 2020. graf
Article Dans Anglais | LILACS | ID: biblio-1088525

Résumé

Abstract Purpose Glutamine, as an essential part of enteral nutrition and parenteral nutrition agent, has been widely recognized to be a kind of important intestinal mucosa protectant in clinical practice and experimental research. However, the mechanisms of its protective effects are still not fully understand. Consequently, this study aimed to explore the potential mechanism of glutamine on ischemia-reperfusion (I/R) injury induced endoplasmic reticulum (ER) stress in intestine. Methods An experimental model of intestinal I/R in rats was established by 1 hour occlusion of the superior mesenteric artery followed by 3 hours of reperfusion. Morphologic changes of intestinal mucosa, apoptosis of epithelial cells, and expression of intestinal Grp78, Gadd153, Caspase-12, ATF4, PERK phosphorylation (P-PERK) and elF2αphosphorylation(P-elF2α) were determined. Results After I/R, the apoptotic index of intestinal mucosa epithelial cells observably increased with notable necrosis of intestinal mucosa, and the expressions of Grp78, Gadd153, Caspase-12, ATF4, P-PERK and P-elF2αall were increased. However, treatment with glutamine could significantly relieve intestinal I/R injury and apoptosis index. Moreover, glutamine could clearly up-regulate the expression of Grp78, restrain P-PERK and P-elF2α, and reduce ATF4, Gadd153 and Caspase-12 expressions. Conclusion Glutamine may be involved in alleviating ER stress induced intestinal mucosa cells apoptosis.


Sujets)
Animaux , Mâle , Lésion d'ischémie-reperfusion/prévention et contrôle , Apoptose/effets des médicaments et des substances chimiques , Agents protecteurs/pharmacologie , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Glutamine/pharmacologie , Muqueuse intestinale/effets des médicaments et des substances chimiques , ARN messager/effets des médicaments et des substances chimiques , Rat Sprague-Dawley , Artère mésentérique supérieure/traumatismes , eIF-2 Kinase/effets des médicaments et des substances chimiques , Modèles animaux , Facteur de transcription ATF-4/effets des médicaments et des substances chimiques , Facteur de transcription CHOP/effets des médicaments et des substances chimiques , Caspase-12/effets des médicaments et des substances chimiques , Protéines du choc thermique/effets des médicaments et des substances chimiques , Muqueuse intestinale , Muqueuse intestinale/ultrastructure
2.
Journal of Zhejiang University. Medical sciences ; (6): 705-713, 2020.
Article Dans Chinois | WPRIM | ID: wpr-879932

Résumé

OBJECTIVE@#To investigate the regulatory effect of iridoid glycoside of radix scrophulariae (IGRS) on endoplasmic reticulum stress induced by oxygen-glucose deprivation and reperfusion @*METHODS@#Rat pheochromocytoma PC12 cells were pretreated with IGRS (50, 100, 200 μg/mL) for 24h, and the @*RESULTS@#The damage caused by OGD/R to PC12 cells was significantly reduced by IGRS, with significant effect on increasing survival rate and reducing LDH release (all @*CONCLUSIONS@#IGRS has neuroprotective effect, which may alleviate cerebral ischemia-reperfusion injury by regulating SERCA2, maintaining calcium balance, and inhibiting endoplasmic reticulum stress-mediated apoptosis.


Sujets)
Animaux , Rats , Survie cellulaire/effets des médicaments et des substances chimiques , Régulation négative/effets des médicaments et des substances chimiques , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Glucose , Techniques in vitro , Glycosides d'iridoïdes/pharmacologie , Oxygène , Cellules PC12 , Reperfusion , Lésion d'ischémie-reperfusion/prévention et contrôle , Escargots/composition chimique
3.
Biol. Res ; 52: 34, 2019. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1019499

Résumé

BACKGROUND: Psoralen is a coumarin-like and coumarin-related benzofuran glycoside, which is a commonly used traditional Chinese medicine to treat patients with kidney and spleen-yang deficiency symptom. Psoralen has been reported to show estrogen-like activity, antioxidant activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity. However, the antitumor mechanism of psoralen is not fully understood. This study aimed to investigate the therapeutic efficacy of psoralen in human hepatoma cell line SMMC7721 and the mechanism of antitumor effects. RESULTS: Psoralen inhibited proliferation of SMMC7721 in a dose- and time-dependent manner, and promoted apoptosis. Further, psoralen activated the ER stress signal pathway, including the expansion of endoplasmic reticulum, increasing the mRNA levels of GRP78, DDIT3, ATF4, XBP1, GADD34 and the protein levels of GDF15, GRP78, IRE1α, XBP-1s in a time-dependent manner. Psoralen induces cell cycle arrest at G1 phase by enhancing CyclinD1 and reducing CyclinE1 expression. Moreover, TUDC couldn't inhibit the psoralen-induced ER stress in SMMC7721 cells. CONCLUSIONS: Psoralen can inhibit the proliferation of SMMC7721 cells and induce ER stress response to induce cell apoptosis, suggesting that psoralen may represent a novel therapeutic option for the prevention and treatment hepatocellular carcinoma.


Sujets)
Humains , Carcinome hépatocellulaire/traitement médicamenteux , Prolifération cellulaire/effets des médicaments et des substances chimiques , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Psoralène/pharmacologie , Tumeurs du foie/traitement médicamenteux , Antinéoplasiques d'origine végétale/pharmacologie , Transduction du signal/effets des médicaments et des substances chimiques , Protein-Serine-Threonine Kinases/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Carcinome hépatocellulaire/anatomopathologie , Lignée cellulaire tumorale , Psoralène/usage thérapeutique , Psoralène/composition chimique , Tumeurs du foie/anatomopathologie
4.
Clinics ; 73: e150, 2018. tab, graf
Article Dans Anglais | LILACS | ID: biblio-974929

Résumé

OBJECTIVES: Dietary omega-3 fatty acids have been efficacious in decreasing serum cholesterol levels and reducing the risk of cardiovascular disease. However, the metabolic and molecular changes induced by the omega-3 fatty acid α-linolenic acid (ALA), which is found in linseed oil, are not fully understood. In this study, we showed a correlation between ALA and insulin resistance, inflammation and endoplasmic reticulum stress (ERS). METHODS: We studied 40 male mice (C57/BL6) divided into 4 groups: a control (C) group, a control + omega-3/ALA (CA) group, a high-fat diet (HFD) (H) group and a high-fat diet + omega-3/ALA (HA) group. For 8 weeks, the animals in the H and HA groups were fed a high-fat (60%) diet, while the animals in the C and CA groups received regular chow. The diets of the CA and HA groups were supplemented with 10% lyophilized ALA. RESULTS: ALA supplementation improved glucose tolerance and reduced insulin resistance, as measured by intraperitoneal glucose tolerance tests and the homeostasis model assessment for insulin resistance, respectively. In addition, ALA reduced hepatic steatosis and modified the standard fat concentration in the liver of animals fed an HFD. Dietary ALA supplementation reduced the serum levels of interleukin 6 (IL-6), interleukin 1 beta (IL-1β) and monocyte chemoattractant protein-1 (MCP-1), increased the expression of important chaperones such as binding immunoglobulin protein (BIP) and heat shock protein 70 (HSP70) and reduced the expression of C/EBP-homologous protein (CHOP) and X-box binding protein 1 (XBP1) in hepatic tissues, suggesting an ERS adaptation in response to ALA supplementation. CONCLUSIONS: Dietary ALA supplementation is effective in preventing hepatic steatosis; is associated with a reduction in insulin resistance, inflammation and ERS; and represents an alternative for improving liver function and obtaining metabolic benefits.


Sujets)
Animaux , Mâle , Souris , Insulinorésistance , Acides gras omega-3/administration et posologie , Acide alpha-linolénique/administration et posologie , Stéatose hépatique/prévention et contrôle , Alimentation riche en graisse , Inflammation/prévention et contrôle , Acides gras omega-3/pharmacologie , Acide alpha-linolénique/pharmacologie , Compléments alimentaires , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Hyperglycémie provoquée , Souris de lignée C57BL
5.
Acta cir. bras ; 32(7): 533-539, July 2017. graf
Article Dans Anglais | LILACS | ID: biblio-886212

Résumé

Abstract Purpose: To investigate the protective mechanisms of propofol (Pro) on renal ischemia/reperfusion (I/R) injury by studying its impact on renal I/R endoplasmic reticulum stress. Methods: Eighteen male Sprague-Dawley rats (SD rats) were randomly divided into three groups: the I/R group, the Pro pretreatment group, and the control group, and corresponding treatments were performed. The levels of serum creatinine (Cr) and blood urea nitrogen (BUN) of each group were detected. The expression levels of CCAAT-enhancer-binding protein (C/EBP) homology protein (CHOP) and caspase-12 protein within renal tissue samples were detected by western blot. Results: The periodic acid-Schiff (PAS) staining was performed to observe the morphological changes within the renal tissues, and the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay was performed to detect the presence of renal apoptosis. The Pro pretreatment significantly reduced the serum Cr and BUN levels, as well as the expressions levels of CHOP and caspase-12 protein inside the kidney of I/R rats, improving renal pathological injury and reducing the I/R-induced renal apoptosis. Conclusion: Propofol could downregulate the expression of stress-apoptotic proteins CHOP and caspase-12 in the endoplasmic reticulum, thus reducing renal I/R injury.


Sujets)
Animaux , Mâle , Rats , Lésion d'ischémie-reperfusion/anatomopathologie , Propofol/pharmacologie , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Rein/anatomopathologie , Répartition aléatoire , Rat Sprague-Dawley
6.
Korean Journal of Ophthalmology ; : 468-478, 2016.
Article Dans Anglais | WPRIM | ID: wpr-160779

Résumé

PURPOSE: To investigate the production of long pentraxin 3 (PTX3) in response to tunicamycin-induced endoplasmic reticulum (ER) stress and its role in ER stress-associated cell death, PTX3 expression was evaluated in the human retinal pigment epithelial cell line, ARPE-19. METHODS: PTX3 production in ARPE-19 cells was analyzed in the absence or presence of tunicamycin treatment by enzyme-linked immunosorbent assay. PTX3 protein and mRNA levels were estimated using western blot analysis and real-time reverse transcription-polymerase chain reaction, respectively. Protein and mRNA levels of CCAAT-enhancer-binding protein homologous protein (CHOP) and ARPE-19 cell viability were measured in the presence of tunicamycin-induced ER stress in control or PTX3 small hairpin RNA (shRNA)-transfected ARPE-19 cells. RESULTS: The protein and mRNA levels of PTX3 were found to be significantly increased by tunicamycin treatment. PTX3 production was significantly decreased in inositol-requiring enzyme 1α shRNA-transfected ARPE-19 cells compared to control shRNA-transfected cells. Furthermore, pretreatment with the NF-κB inhibitor abolished tunicamycin-induced PTX3 production. Decreased cell viability and prolonged protein and mRNA expression of CHOP were observed under tunicamycin-induced ER stress in PTX3 shRNA transfected ARPE-19 cells. CONCLUSIONS: These results suggest that PTX3 production increased in the presence of tunicamycin-induced ER stress. Therefore, PTX3 could be an important protector of ER stress-induced cell death in human retinal pigment epithelial cells. Inositol-requiring enzyme 1α and the NF-κB signaling pathway may serve as potential targets for regulation of PTX3 expression in the retina. Therefore, their role in PTX3 expression needs to be further investigated.


Sujets)
Humains , Antibactériens/pharmacologie , Apoptose , Technique de Western , Protéine C-réactive/biosynthèse , Cellules cultivées , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Test ELISA , Régulation de l'expression des gènes , Réaction de polymérisation en chaîne , ARN messager/génétique , Épithélium pigmentaire de la rétine/métabolisme , Composant sérique amyloïde P/biosynthèse , Tunicamycine/pharmacologie
7.
The Korean Journal of Internal Medicine ; : 339-346, 2013.
Article Dans Anglais | WPRIM | ID: wpr-155786

Résumé

BACKGROUND/AIMS: beta-Cell apoptosis caused by increased endoplasmic reticulum (ER) stress is an important pathogenic component of type 2 diabetes mellitus. In theory, sulfonylureas, used for the treatment of diabetes, can contribute to ER stress. We assessed changes in ER stress in pancreatic beta-cells under glucotoxic or glucolipotoxic conditions using low concentrations of the sulfonylurea, glibenclamide (GB). METHODS: Low concentrations of GB (10 or 100 nM) were added to INS-1 cells cultured under glucotoxic or glucolipotoxic conditions. The degree of viability, level of apoptosis and levels of markers associated with ER stress were measured. RESULTS: Apoptosis decreased in response to low concentrations of GB under glucolipotoxic but not glucotoxic conditions. Most ER stress markers decreased upon the addition of GB. Under glucotoxic conditions, changes in the levels of ER stress markers were not consistent. However, all decreased significantly under glucolipotoxic conditions. CONCLUSIONS: Low concentrations of GB exerted antiapoptotic effects through the attenuation of ER stress under glucolipotoxic conditions.


Sujets)
Animaux , Rats , Apoptose/effets des médicaments et des substances chimiques , Marqueurs biologiques/métabolisme , Lignée cellulaire tumorale , Survie cellulaire/effets des médicaments et des substances chimiques , Diabète/traitement médicamenteux , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Glibenclamide/pharmacologie , Hypoglycémiants/pharmacologie
8.
Experimental & Molecular Medicine ; : 562-570, 2012.
Article Dans Anglais | WPRIM | ID: wpr-211930

Résumé

Mitochondrial dysfunction and endoplasmic reticulum (ER) stress are considered the key determinants of insulin resistance. Impaired mitochondrial function in obese animals was shown to induce the ER stress response, resulting in reduced adiponectin synthesis in adipocytes. The expression of inducible nitric oxide synthase (iNOS) is increased in adipose tissues in genetic and dietary models of obesity. In this study, we examined whether activation of iNOS is responsible for palmitate-induced mitochondrial dysfunction, ER stress, and decreased adiponectin synthesis in 3T3L1 adipocytes. As expected, palmitate increased the expression levels of iNOS and ER stress response markers, and decreased mitochondrial contents. Treatment with iNOS inhibitor increased adiponectin synthesis and reversed the palmitate-induced ER stress response. However, the iNOS inhibitor did not affect the palmitate-induced decrease in mitochondrial contents. Chemicals that inhibit mitochondrial function increased iNOS expression and the ER stress response, whereas measures that increase mitochondrial biogenesis (rosiglitazone and adenoviral overexpression of nuclear respiratory factor-1) reversed them. Inhibition of mitochondrial biogenesis prevented the rosiglitazone-induced decrease in iNOS expression and increase in adiponectin synthesis. These results suggest that palmitate-induced mitochondrial dysfunction is the primary event that leads to iNOS induction, ER stress, and decreased adiponectin synthesis in cultured adipocytes.


Sujets)
Animaux , Souris , Cellules 3T3-L1 , Adipocytes/effets des médicaments et des substances chimiques , Adiponectine/biosynthèse , Tissu adipeux/métabolisme , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Insulinorésistance/génétique , Mitochondries/effets des médicaments et des substances chimiques , Renouvellement des mitochondries/effets des médicaments et des substances chimiques , Nitric oxide synthase type II/génétique , Facteur nucléaire-1 respiratoire , Obésité/génétique , Acide palmitique/pharmacologie , Thiazolidinediones/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche